1Sudoh A, Sugai K, Miyamoto T. Non-intravenous highdose phenobarbital therapy for status epilepticus refractory to continuous infusion of midazolam or pentobarbital: report of three cases[J]. No To Hattatsu, 2002,34 (1): 23～ 29.
2Seegers U, Potschka H, Loscher W. Transient increase of Pglycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy[J]. Epilepsy Res, 2002,51(3) :257～268.
3Misra S,Singh NN. Management of status epilepticus[J]. J Indian Med Assoc, 2002,100(5):299-303.
4Parviainen I, Uusaro A, Kalviainen R,et al. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit[J]. Neurology, 2002, 22, 59(8):1249-1251.
5Niermeijer JM, Uiterwaal CS, Van Donselaar CA. Propofol in status epilepticus: little evidence, many dangers[J] ? J Neurol, 2003,250(10): 1237-1240.
6Towne AR, Garnett LK, Waterhouse EJ. The use of topiramate in refractory status epilepticus[J]. Neurology, 2003,60(2) :332-334.
7Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review[J]. Epilepsia, 2002,43(2):146-153.
8Winston KR, Levisohn P, Miller BR, et al. Vagal nerve stimulation for status epilepticus [J]. Pediatr Neurosurg,2001,34(4) : 190- 192.
9Mayer SA, Claassen J, Lokin J,et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome[J].Arch Neurol,2002,59(2) :205-210.
10Sisodiya SM, Thom M. Widespread upregulation of drug-resistance proteins in fatal human status epilepticus[J]. Epilepsia, 2003,44(2) :261-264.
